Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
6.49
+0.29 (4.68%)
Aug 13, 2025, 4:00 PM - Market closed
Kura Oncology Analyst Ratings
Total Analysts
13
Consensus Rating
Strong Buy
Price Target
$24.45
Upside
+276.73%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Maintains $28 → $24 | Buy | Maintains | $28 → $24 | +269.80% | Aug 11, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 26, 2025 |
| Wedbush | Wedbush | Buy Reiterates $36 | Buy | Reiterates | $36 | +454.70% | Jun 20, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $28 | Buy | Reiterates | $28 | +331.43% | Jun 4, 2025 |
| Mizuho | Mizuho | Buy Maintains $32 → $30 | Buy | Maintains | $32 → $30 | +362.25% | May 19, 2025 |
| Barclays | Barclays | Buy Maintains $32 → $11 | Buy | Maintains | $32 → $11 | +69.49% | May 2, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $28 | Buy | Reiterates | $28 | +331.43% | Apr 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +516.33% | Apr 28, 2025 |
| UBS | UBS | Strong Buy Maintains $27 → $14 | Strong Buy | Maintains | $27 → $14 | +115.72% | Mar 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +516.33% | Feb 27, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $28 | Buy | Reiterates | $28 | +331.43% | Feb 6, 2025 |
| Wedbush | Wedbush | Buy Maintains $34 → $36 | Buy | Maintains | $34 → $36 | +454.70% | Feb 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $37 → $40 | Strong Buy | Maintains | $37 → $40 | +516.33% | Feb 6, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $18 → $10 | Hold | Maintains | $18 → $10 | +54.08% | Jan 8, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Dec 9, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Nov 26, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.